Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-07-30 Purchase | 2024-07-31 4:19 pm | Adverum Biotechnologies Inc. | ADVM | Leonard Braden Michael 10% Owner | 85,800 | $7.15 | $613,470 | 2,372,864 (Indirect Direct) | View |
| 2024-07-17 Purchase | 2024-07-18 9:16 pm | Adverum Biotechnologies Inc. | ADVM | Leonard Braden Michael 10% Owner | 216,264 | $8.2569 | $1,785,662 | 2,287,064 (Indirect Direct) | View |
| 2024-02-07 Purchase | 2024-02-09 5:51 pm | Adverum Biotechnologies Inc. | ADVM | Scopa James Paul Director | 100,000 | $1.35 | $135,000 | 103,334 (Indirect Direct) | View |
| 2024-02-07 Purchase | 2024-02-09 5:50 pm | Adverum Biotechnologies Inc. | ADVM | Lupher Jr. Mark L. Director | 130,000 | $1.35 | $175,500 | 130,000 (Direct) | View |
| 2023-09-15 Sale | 2023-09-18 6:54 pm | Adverum Biotechnologies Inc. | ADVM | Seyedkazemi Setareh Chief Development Officer | 6,201 | $1.5206 | $9,429 | 47,674 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-08-02 Option Award | 2024-08-06 4:10 pm | N/A 2034-08-01 | Adverum Biotechnologies Inc. | ADVM | Ozden Rabia Gurses Chief Medical Officer | 44,010 | $0 | 44,010 (Direct) | View |
| 2024-08-02 Option Award | 2024-08-06 4:10 pm | N/A 2034-08-01 | Adverum Biotechnologies Inc. | ADVM | Rubinstein Linda M CHIEF FINANCIAL OFFICER | 62,083 | $0 | 62,083 (Direct) | View |
| 2024-08-02 Option Award | 2024-08-06 4:09 pm | N/A 2034-08-01 | Adverum Biotechnologies Inc. | ADVM | Seyedkazemi Setareh CHIEF DEVELOPMENT OFFICER | 43,458 | $0 | 43,458 (Direct) | View |
| 2024-08-02 Option Award | 2024-08-06 4:09 pm | N/A 2034-08-01 | Adverum Biotechnologies Inc. | ADVM | Soparkar Peter CHIEF OPERATING OFFICER | 64,394 | $0 | 64,394 (Direct) | View |
| 2024-08-02 Option Award | 2024-08-06 4:08 pm | N/A 2034-08-01 | Adverum Biotechnologies Inc. | ADVM | Fischer Laurent CEO, PRESIDENT AND DIRECTOR | 200,000 | $0 | 200,000 (Direct) | View |
Ownership | 2024-07-18 9:16 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Leonard Braden Michael 10% Owner | 0 | $0 | 2,207,976 (Indirect) | View |
| 2024-06-17 Option Award | 2024-06-20 4:50 pm | N/A 2034-06-16 | Adverum Biotechnologies Inc. | ADVM | Ozden Rabia Gurses Chief Medical Officer | 85,000 | $0 | 85,000 (Direct) | View |
| 2024-06-17 Option Award | 2024-06-20 4:49 pm | N/A 2034-06-16 | Adverum Biotechnologies Inc. | ADVM | Nicholson C. David Director | 10,520 | $0 | 10,520 (Direct) | View |
| 2024-06-17 Option Award | 2024-06-20 4:48 pm | N/A 2034-06-16 | Adverum Biotechnologies Inc. | ADVM | Hong Soo Director | 10,520 | $0 | 10,520 (Direct) | View |
| 2024-06-17 Option Award | 2024-06-20 4:48 pm | N/A 2034-06-16 | Adverum Biotechnologies Inc. | ADVM | Lupher Jr. Mark L. Director | 10,520 | $0 | 10,520 (Direct) | View |
| 2024-06-17 Option Award | 2024-06-20 4:47 pm | N/A 2034-06-16 | Adverum Biotechnologies Inc. | ADVM | Svoronos Dawn Director | 10,520 | $0 | 10,520 (Direct) | View |
| 2024-06-17 Option Award | 2024-06-20 4:46 pm | N/A 2034-06-16 | Adverum Biotechnologies Inc. | ADVM | Tuckson Reed Vaughn Director | 10,520 | $0 | 10,520 (Direct) | View |
| 2024-06-17 Option Award | 2024-06-20 4:45 pm | N/A 2034-06-16 | Adverum Biotechnologies Inc. | ADVM | Whitcup Scott M Director | 10,520 | $0 | 10,520 (Direct) | View |
| 2024-06-17 Option Award | 2024-06-20 4:44 pm | N/A 2034-06-16 | Adverum Biotechnologies Inc. | ADVM | Scopa James Paul Director | 10,520 | $0 | 10,520 (Direct) | View |
| 2024-06-17 Option Award | 2024-06-20 4:43 pm | N/A 2034-06-16 | Adverum Biotechnologies Inc. | ADVM | Machado Patrick Director | 13,820 | $0 | 13,820 (Direct) | View |
| 2024-06-17 Option Award | 2024-06-20 4:43 pm | N/A 2034-06-16 | Adverum Biotechnologies Inc. | ADVM | Kiss Szilard Director | 21,040 | $0 | 21,040 (Direct) | View |
Ownership | 2024-06-20 4:42 pm | N/A 2026-11-01 | Adverum Biotechnologies Inc. | ADVM | Kiss Szilard Director | 0 | $0 | 20,750 (Direct) | View |
| 2023-10-03 Option Award | 2024-03-12 7:07 pm | N/A 2032-03-07 | Adverum Biotechnologies Inc. | ADVM | Seyedkazemi Setareh CHIEF DEVELOPMENT OFFICER | 85,000 | $0 | 85,000 (Direct) | View |
| 2023-10-03 Option Award | 2024-03-12 7:06 pm | N/A 2032-03-07 | Adverum Biotechnologies Inc. | ADVM | Soparkar Peter CHIEF OPERATING OFFICER | 130,000 | $0 | 130,000 (Direct) | View |
| 2023-10-03 Option Award | 2024-03-12 7:05 pm | N/A 2032-03-07 | Adverum Biotechnologies Inc. | ADVM | Fischer Laurent CEO, PRESIDENT AND DIRECTOR | 315,000 | $0 | 315,000 (Direct) | View |
| 2024-02-12 Option Award | 2024-02-14 4:33 pm | N/A 2034-02-11 | Adverum Biotechnologies Inc. | ADVM | Seyedkazemi Setareh CHIEF DEVELOPMENT OFFICER | 400,000 | $0 | 400,000 (Direct) | View |
| 2024-02-12 Option Award | 2024-02-14 4:31 pm | N/A 2034-02-11 | Adverum Biotechnologies Inc. | ADVM | Fischer Laurent CEO, PRESIDENT AND DIRECTOR | 1,104,200 | $0 | 1,104,200 (Direct) | View |
| 2024-02-12 Option Award | 2024-02-14 4:29 pm | N/A 2034-02-11 | Adverum Biotechnologies Inc. | ADVM | Rubinstein Linda M CHIEF FINANCIAL OFFICER | 350,000 | $0 | 350,000 (Direct) | View |
| 2024-02-12 Option Award | 2024-02-14 4:27 pm | N/A 2034-02-11 | Adverum Biotechnologies Inc. | ADVM | Soparkar Peter CHIEF OPERATING OFFICER | 450,000 | $0 | 450,000 (Direct) | View |
| 2023-11-03 Option Award | 2023-11-06 7:54 pm | N/A 2033-11-02 | Adverum Biotechnologies Inc. | ADVM | Nicholson C. David Director | 80,000 | $0 | 80,000 (Direct) | View |
Ownership | 2023-11-06 7:52 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Nicholson C. David Director | 0 | $0 | 0 (Direct) | View |
| 2023-08-03 Option Award | 2023-09-05 4:14 pm | N/A 2033-08-02 | Adverum Biotechnologies Inc. | ADVM | Rubinstein Linda M Chief Financial Officer | 850,000 | $0 | 850,000 (Direct) | View |
| 2023-06-09 Option Award | 2023-06-13 6:19 pm | N/A 2033-06-08 | Adverum Biotechnologies Inc. | ADVM | Ozden Rabia Gurses Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-09 Option Award | 2023-06-13 5:17 pm | N/A 2033-06-08 | Adverum Biotechnologies Inc. | ADVM | Scopa James Paul Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-09 Option Award | 2023-06-13 5:15 pm | N/A 2033-06-08 | Adverum Biotechnologies Inc. | ADVM | Whitcup Scott M Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-09 Option Award | 2023-06-13 5:13 pm | N/A 2033-06-08 | Adverum Biotechnologies Inc. | ADVM | Tuckson Reed Vaughn Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-09 Option Award | 2023-06-13 5:10 pm | N/A 2033-06-08 | Adverum Biotechnologies Inc. | ADVM | Svoronos Dawn Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-09 Option Award | 2023-06-13 5:05 pm | N/A 2033-06-08 | Adverum Biotechnologies Inc. | ADVM | Lupher Jr. Mark L. Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-09 Option Award | 2023-06-13 5:03 pm | N/A 2033-06-08 | Adverum Biotechnologies Inc. | ADVM | Hong Soo Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-09 Option Award | 2023-06-13 5:02 pm | N/A 2033-06-08 | Adverum Biotechnologies Inc. | ADVM | Machado Patrick Director | 52,500 | $0 | 92,500 (Direct) | View |